Follow the DeltaーFly Pharma株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, DeltaーFly Pharma株式会社 has logged 51 public disclosures. Market capitalisation: €1.5bn. The latest transaction was reported on 17 August 2026 (Holding update). Among the most active insiders: Macquarie Bank Limited. The full history is accessible without an account.
51
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Delta-Fly Pharma es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XTKS. Se centra en el desarrollo de tratamientos y soluciones terapéuticas innovadoras.